Option Agreement to License and Commercialize Pan-Cancer Test Algorithm Sample Contracts

October 26, 2017

Option Agreement to License and Commercialize Pan-Cancer Test Algorithm • June 22nd, 2018 • 20/20 GeneSystems, Inc. • Services-testing laboratories

• Contract Type
  Option Agreement to License and Commercialize Pan-Cancer Test Algorithm
• Filed
  June 22nd, 2018
• Company
  20/20 GeneSystems, Inc.
• Industry
  Services-testing laboratories

Pursuant to discussions between the Parties, the Option Agreement to License and Commercialize Pan-Cancer Test Algorithm (“Agreement”) between CGMH and 20/20 GeneSystems shall be amended as follows: